MedTrace Logo

Psychiatric Multi-omics and Neuroimaging Project

NCT06580860 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1899

Last updated 2026-03-13

No results posted yet for this study

Summary

This study focuses on the structure and function of the brain and gene expression in peripheral blood of patients with schizophrenia, to explore the interaction and influence between the three. Patients with mental disorders who have been recruited will take their medication regularly for 1 year and participate in baseline and follow-up assessments.

Conditions

  • Mental Disorders
  • Healthy Control

Interventions

DRUG

Antipsychotic drugs, antidepressants, mood stabilizers, and sleep aids

Patients with mental disorders should take the appropriate medicine as prescribed by the doctor，and the health norms are not required to take medicine.This study will not interfere with the medication regimen of doctors.

Sponsors & Collaborators

  • mingjun Zhong

    lead OTHER

Eligibility

Min Age
13 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06580860 on ClinicalTrials.gov